Literature DB >> 22318636

Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.

Moan Shane Tsai1, Yun Liang Yang, An Huei Wang, Lih Shinn Wang, Daniel C T Lu, Ci Hong Liou, Li Yun Hsieh, Chi Jung Wu, Ming Fang Cheng, Zhi Yuan Shi, Hsiu Jung Lo.   

Abstract

A total of 35 Trichosporon isolates were collected from the Taiwan Surveillance of Antimicrobial Resistance of Yeasts (TSARY) project from 1999 to 2006, and their identifications as well as drug susceptibilities were determined. The most frequently isolated species was T. asahii (62.9%), and the most common clinical sample that yielded Trichosporon isolates was urine (37.1%). The etiology of all seven invasive trichosporonosis was T. asahii. For the 22 T. asahii isolates, the MIC(50) and MIC(90) for amphotericin B were 0.25 and 1 μg/mL, respectively. Those for fluconazole were 2 and 4 μg/mL, respectively, and for voriconazole 0.031 and 0.063 μg/mL, respectively. When the intraclass correlation coefficients (ICCs) and agreements were calculated, we found that the MICs of fluconazole obtained from different methods were similar and the inter-method discrepancies were low. Nevertheless, no unanimous MIC of amphotericin B and voriconazole was obtained among different methods.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318636     DOI: 10.1007/s11046-012-9525-z

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  34 in total

1.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Susceptibility patterns and molecular identification of Trichosporon species.

Authors:  Juan L Rodriguez-Tudela; Teresa M Diaz-Guerra; Emilia Mellado; Virginia Cano; Cecilia Tapia; Alexander Perkins; Alicia Gomez-Lopez; Laura Rodero; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan.

Authors:  Y L Yang; M F Cheng; C W Wang; A H Wang; W T Cheng; H J Lo; Tsary Hospitals
Journal:  Med Mycol       Date:  2010-03       Impact factor: 4.076

4.  Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.

Authors:  Yun-Liang Yang; Shu-Ying Li; Hsiao-Hsu Cheng; Hsiu-Jung Lo
Journal:  Diagn Microbiol Infect Dis       Date:  2005-03       Impact factor: 2.803

5.  Marked renal damage in a child with hydronephrosis infected by Trichosporon asahii.

Authors:  Yukiko Mori; Masahiro Hiraoka; Masakazu Katsu; Hirokazu Tsukahara; Yuzuru Mikami; Mitsufumi Mayumi
Journal:  Pediatr Nephrol       Date:  2004-12-30       Impact factor: 3.714

6.  Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.

Authors:  Mariceli Araujo Ribeiro; Ana Alastruey-Izquierdo; Alicia Gomez-Lopez; Juan Luis Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  Rev Iberoam Micol       Date:  2008-12-31       Impact factor: 1.044

7.  Granuloma associated with Trichosporon asahii infection in the lung: Unusual pathological findings and PCR detection of Trichosporon DNA.

Authors:  Masamitsu Nakajima; Takashi Sugita; Yoshiki Mikami
Journal:  Med Mycol       Date:  2007-11       Impact factor: 4.076

8.  Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.

Authors:  Shiang Ning Leaw; Hsien Chang Chang; Hsiao Fang Sun; Richard Barton; Jean-Philippe Bouchara; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

9.  In vitro activity of voriconazole against selected fungi.

Authors:  M R McGinnis; L Pasarell; D A Sutton; A W Fothergill; C R Cooper; M G Rinaldi
Journal:  Med Mycol       Date:  1998-08       Impact factor: 4.076

Review 10.  Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy.

Authors:  R A Hajjeh; H M Blumberg
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

View more
  7 in total

1.  Trichosporon inkin: an uncommon agent of scalp white piedra. Report of four cases in Brazilian children.

Authors:  Olga Fischman; Fabiane Castilho Bezerra; Elaine Cristina Francisco; Flávia Cristina da Silva; Angela Satie Nishikaku; Sarah Desirée Barbosa Cavalcanti; Analy Salles de Azevedo Melo; Henri Donnarumma Levy Bentubo; Valéria Petri
Journal:  Mycopathologia       Date:  2014-06-21       Impact factor: 2.574

2.  Trichosporon loubieri Fungemia in a 39-Year-Old Caucasian Woman With B-Cell Lymphoblastic Leukemia.

Authors:  Archana Bhaskaran; Karam M Obeid; Sophie Arbefeville; Patricia Ferrieri
Journal:  Lab Med       Date:  2016-08

3.  Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.

Authors:  M Treviño; C García-Riestra; P Areses; X García; D Navarro; F J Suárez; I A López-Dequidt; O Zaragoza; M Cuenca-Estrella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-10       Impact factor: 3.267

4.  Trichosporon faecale invasive infection in a patient with severe aplastic anemia: Efficacy of voriconazole and liposomal amphotericin B before neutrophil recovery.

Authors:  Baptiste Pérard; Amandine Rougeron; Simon Favre; Isabelle Accoceberry; Stéphane Vigouroux; Catherine Mohr; Noël Milpied
Journal:  Med Mycol Case Rep       Date:  2015-07-02

5.  In Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahii.

Authors:  Suteng Yang; Yong Liao; Lin Cong; Xuelian Lu; Rongya Yang
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

Review 6.  Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.

Authors:  João N de Almeida Júnior; Christophe Hennequin
Journal:  Front Microbiol       Date:  2016-10-17       Impact factor: 5.640

Review 7.  Rare fungal infectious agents: a lurking enemy.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  F1000Res       Date:  2017-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.